犬用ワクチン市場：ワクチンタイプ別、技術別、エンドユーザー別、流通チャネル別、用途別、年齢層別、犬サイズ別-2025-2030年世界予測

犬用ワクチン市場は、2023年に20億5,000万米ドルと評価され、2024年には22億1,000万米ドルに達すると予測され、CAGR 8.03％で成長し、2030年には35億2,000万米ドルに達すると予測されています。

犬の病気を対象とした予防医療ソリューションを包括する犬用ワクチン市場は、ペット飼育の増加、動物の健康に対する意識の高まり、獣医学の進歩により、大きな成長が見込まれています。狂犬病、パルボウイルス、ジステンパーなどの病気の予防にはワクチン接種が不可欠であり、ペットだけでなく公衆衛生も守っています。犬用ワクチンの用途は、普遍的に推奨される中核的なワクチンから、特定の地域や犬のライフスタイルを対象とした非中核的・特殊なワクチンまで多岐にわたります。これらのワクチンの最終用途は、動物病院、ペット病院、移動式動物病院で広く普及しています。市場成長は、ペットヘルスケアに対する需要の高まり、ワクチン技術の進歩、飼い主の予防対策への関心の高まりといった要因に大きく影響されます。ペットの飼育数が増加している新興国市場や、ワクチン接種プロセスを合理化する混合ワクチンの開発にはビジネスチャンスが豊富にあります。企業は、投与しやすいワクチンの革新、効能の向上、流通網の拡大により、こうした機会を活用することができます。とはいえ、市場開拓は、ワクチン開発に伴う高コスト、規制の複雑さ、ワクチンに対する抵抗感や飼い主の懐疑心といった課題に直面しています。まれにではあるが、副反応も広く受け入れられることを制限する可能性があります。このような課題を克服するために、企業はワクチン送達システムの革新やワクチンの安全性プロファイルの改善を目指し、強力な研究開発に注力すべきです。市場の競争は激しく、主要企業は多様な製品ポートフォリオを通じてシェア拡大を目指し、絶え間ない技術革新を続けています。パーソナライズされたワクチン・スケジュールのためのAI主導型データ分析など、技術的統合の増加は、将来の探求のための肥沃な土壌を表しています。また、公開会社は、社会的信頼と規制遵守を強化し、犬用ワクチンの受容と応用の上昇軌道を確実にするために、政府機関や保健機関との連携を検討すべきです。

市場力学：急速に進化する犬用ワクチン市場の主要市場インサイトを公開

犬用ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ペット飼育の増加と動物の健康と予防接種に対する意識の高まり
  • ペットの予防接種義務化と動物の疾病管理を支援する政府の取り組みと規制
  • 人獣共通感染症の増加と予防におけるワクチンの役割
  • 獣医学の進歩とペットヘルスケア・インフラへの投資の増加
• 市場抑制要因
  • 犬のワクチン接種の重要性に関する飼い主の認識と教育の欠如
  • 規制要件が厳しく、犬用ワクチンの承認プロセスに時間がかかるため、遅れが生じています。
• 市場機会
  • 一般的な犬の病気に対してより効果的なワクチンの開発につながるバイオテクノロジーの進歩
  • 副作用の少ない次世代の犬用ワクチンの研究開発への投資の増加
  • 革新的なワクチンソリューションを創出するための動物用医薬品企業と研究機関の連携
• 市場の課題
  • 犬用ワクチンの承認と販売に関する規制状況の変化への対応
  • 犬用ワクチン産業における研究開発・生産コストの上昇とのバランス

ポーターの5つの力：犬用ワクチン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：犬用ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、犬用ワクチン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析犬用ワクチン市場における競合情勢の把握

犬用ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス犬用ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、犬用ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨犬用ワクチン市場における成功への道筋を描く

犬用ワクチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットの飼育数の増加と動物の健康と予防接種に関する意識の高まり
    • ペットのワクチン接種義務と動物疾病管理を支援する政府の取り組みと規制
    • 人獣共通感染症の発生率の上昇と予防におけるワクチンの役割
    • 獣医学の進歩とペットヘルスケアインフラへの投資増加
  • 抑制要因
    • 犬のワクチン接種の重要性に関するペット飼い主の認識と教育の欠如
    • 厳格な規制要件と犬用ワクチンの長い承認プロセスにより遅延が発生しています
  • 機会
    • バイオテクノロジーの進歩により、一般的な犬の病気に対するより効果的なワクチンの開発が進む
    • 副作用の少ない次世代犬用ワクチンの研究開発への投資増加
    • 革新的なワクチンソリューションを生み出すための動物用医薬品企業と調査機関の連携
  • 課題
    • 犬用ワクチンの承認と配布に関する変動する規制環境への対応
    • 犬用ワクチン業界における調査、開発、生産のコスト上昇のバランスをとる
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 犬用ワクチン市場ワクチンの種類別

• コアワクチン
  • 犬アデノウイルス
  • 犬ジステンパーウイルス
  • 犬パルボウイルス
  • 狂犬病
• 非コアワクチン
  • ボルデテラ・ブロンキセプティカ
  • ボレリア・ブルグドルフェリ
  • レプトスピラ・カニコラ

第7章 犬用ワクチン市場：技術別

• DNAワクチン
• 不活化ワクチン
• 生弱毒化ワクチン
• 組み換えワクチン

第8章 犬用ワクチン市場：エンドユーザー別

• 動物病院
• ペットクリニック
• 調査機関
• 獣医クリニック

第9章 犬用ワクチン市場：流通チャネル別

• オンライン薬局
• 小売薬局
• ワクチン接種キャンプ
• 獣医クリニックと病院

第10章 犬用ワクチン市場：用途別

• 病気の予防
• 治療的

第11章 犬用ワクチン市場：年齢層別

• 成犬
• 子犬
• シニア犬

第12章 犬用ワクチン市場犬のサイズ別

• 巨大種
• 大型犬
• 中型犬
• 小型犬

第13章 南北アメリカの犬用ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域の犬用ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの犬用ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Aratana Therapeutics, Inc.
• 2. Bayer Animal Health GmbH
• 3. Biogenesis Bago
• 4. Boehringer Ingelheim Animal Health
• 5. Ceva Sante Animale
• 6. Chanelle Pharma Group
• 7. Dechra Pharmaceuticals PLC
• 8. Elanco Animal Health Incorporated
• 9. Heska Corporation
• 10. Hipra
• 11. IDEXX Laboratories, Inc.
• 12. Intas Pharmaceuticals Ltd.
• 13. Kyoritsu Seiyaku Corporation
• 14. Merck & Co., Inc.
• 15. Merial Ltd.
• 16. Neogen Corporation
• 17. Phibro Animal Health Corporation
• 18. Vetoquinol S.A.
• 19. Virbac S.A.
• 20. Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. DOG VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. DOG VACCINES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2023 VS 2030 (%)
• FIGURE 19. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 23. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 28. DOG VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 29. DOG VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DOG VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DOG VACCINES MARKET DYNAMICS
• TABLE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE ADENOVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE DISTEMPER VIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DOG VACCINES MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DOG VACCINES MARKET SIZE, BY BORDETELLA BRONCHISEPTICA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DOG VACCINES MARKET SIZE, BY BORRELIA BURGDORFERI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DOG VACCINES MARKET SIZE, BY LEPTOSPIRA CANICOLA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DOG VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DOG VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DOG VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DOG VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DOG VACCINES MARKET SIZE, BY PET CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DOG VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DOG VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINATION CAMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL DOG VACCINES MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL DOG VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL DOG VACCINES MARKET SIZE, BY ADULT DOGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL DOG VACCINES MARKET SIZE, BY PUPPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL DOG VACCINES MARKET SIZE, BY SENIOR DOGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL DOG VACCINES MARKET SIZE, BY GIANT BREED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL DOG VACCINES MARKET SIZE, BY LARGE BREED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL DOG VACCINES MARKET SIZE, BY MEDIUM BREED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL DOG VACCINES MARKET SIZE, BY SMALL BREED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 74. CANADA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. CANADA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 76. CANADA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 77. CANADA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. CANADA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. CANADA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. CANADA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. CANADA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 82. CANADA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 121. CHINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. CHINA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 123. CHINA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 124. CHINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. CHINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. CHINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. CHINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. CHINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 129. CHINA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 130. INDIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. INDIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 132. INDIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 133. INDIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. INDIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. INDIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. INDIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. INDIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 138. INDIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 141. INDONESIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 142. INDONESIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. INDONESIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. JAPAN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 150. JAPAN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 151. JAPAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. JAPAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 156. JAPAN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 157. MALAYSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 158. MALAYSIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 159. MALAYSIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 160. MALAYSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. MALAYSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. MALAYSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 165. MALAYSIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 166. PHILIPPINES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 167. PHILIPPINES DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 168. PHILIPPINES DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 169. PHILIPPINES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. PHILIPPINES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. PHILIPPINES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. PHILIPPINES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 174. PHILIPPINES DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 175. SINGAPORE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SINGAPORE DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 177. SINGAPORE DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 178. SINGAPORE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. SINGAPORE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. SINGAPORE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. SINGAPORE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 183. SINGAPORE DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH KOREA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH KOREA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 186. SOUTH KOREA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 190. SOUTH KOREA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. SOUTH KOREA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 192. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 193. TAIWAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. TAIWAN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 195. TAIWAN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 196. TAIWAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. TAIWAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 199. TAIWAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. TAIWAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 201. TAIWAN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 202. THAILAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 203. THAILAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 204. THAILAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 205. THAILAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. THAILAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 208. THAILAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. THAILAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 210. THAILAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 211. VIETNAM DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 212. VIETNAM DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 213. VIETNAM DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 214. VIETNAM DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. VIETNAM DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 217. VIETNAM DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. VIETNAM DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 219. VIETNAM DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 230. DENMARK DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 231. DENMARK DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 232. DENMARK DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 233. DENMARK DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. DENMARK DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 236. DENMARK DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. DENMARK DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 238. DENMARK DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 239. EGYPT DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 240. EGYPT DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 241. EGYPT DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 242. EGYPT DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 244. EGYPT DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 245. EGYPT DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. EGYPT DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 247. EGYPT DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 249. FINLAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 251. FINLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 253. FINLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 254. FINLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 255. FINLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 256. FINLAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 258. FRANCE DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 260. FRANCE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 262. FRANCE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 263. FRANCE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. FRANCE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 265. FRANCE DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 267. GERMANY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 269. GERMANY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 271. GERMANY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 272. GERMANY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. GERMANY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 274. GERMANY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 275. ISRAEL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 276. ISRAEL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 277. ISRAEL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 278. ISRAEL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 280. ISRAEL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 281. ISRAEL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. ISRAEL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 283. ISRAEL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 284. ITALY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 285. ITALY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 286. ITALY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 287. ITALY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 288. ITALY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 289. ITALY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 290. ITALY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 291. ITALY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 292. ITALY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 293. NETHERLANDS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 294. NETHERLANDS DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 295. NETHERLANDS DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 296. NETHERLANDS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 297. NETHERLANDS DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 298. NETHERLANDS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 299. NETHERLANDS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 300. NETHERLANDS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 301. NETHERLANDS DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 302. NIGERIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 303. NIGERIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 304. NIGERIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 305. NIGERIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 306. NIGERIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 307. NIGERIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 308. NIGERIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 309. NIGERIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 310. NIGERIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 311. NORWAY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 312. NORWAY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 313. NORWAY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 314. NORWAY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 315. NORWAY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 316. NORWAY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 317. NORWAY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 318. NORWAY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 319. NORWAY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 320. POLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 321. POLAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 322. POLAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 323. POLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 324. POLAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 325. POLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 326. POLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 327. POLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 328. POLAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 329. QATAR DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 330. QATAR DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 331. QATAR DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 332. QATAR DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 333. QATAR DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 334. QATAR DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 335. QATAR DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 336. QATAR DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 337. QATAR DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 338. RUSSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 339. RUSSIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 340. RUSSIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 341. RUSSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 342. RUSSIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 343. RUSSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 344. RUSSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 345. RUSSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 346. RUSSIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 347. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 348. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 349. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 350. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 351. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 352. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 353. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 354. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 355. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 356. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 357. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 358. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 359. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 360. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 361. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 362. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 363. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 364. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 365. SPAIN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 366. SPAIN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 367. SPAIN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
• TABLE 368. SPAIN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 369. SPAIN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 370. SPAIN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 371. SPAIN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 372. SPAIN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 373. SPAIN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
• TABLE 374. SWEDEN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
• TABLE 375. SWEDEN DOG VACCINES MARKET SIZE, BY C

The Dog Vaccines Market was valued at USD 2.05 billion in 2023, expected to reach USD 2.21 billion in 2024, and is projected to grow at a CAGR of 8.03%, to USD 3.52 billion by 2030.

The market for dog vaccines, which encompasses preventive healthcare solutions targeted at canine diseases, is poised for significant growth due to increased pet ownership, rising awareness of animal health, and advancements in veterinary medicine. Vaccination is essential for preventing diseases like rabies, parvovirus, and distemper, safeguarding not just the pets but also public health. Applications of dog vaccines span core vaccines that are universally recommended to non-core and specialized vaccines intended for specific regions or canine lifestyles. End-use of these vaccines is prevalent in veterinary clinics, pet hospitals, and mobile veterinary units. Market growth is heavily influenced by factors like the escalating demand for pet healthcare, advances in vaccine technology, and increased focus on preventive measures among pet owners. Opportunities abound in developing markets with growing pet ownership and in creating combination vaccines that streamline the vaccination process. Companies can capitalize on these opportunities by innovating easy-to-administer vaccines, enhancing efficacy, and expanding their distribution networks. Nevertheless, the market faces challenges such as high costs associated with vaccine development, regulatory complexities, and occasional vaccine resistance and skepticism among pet owners. Adverse reactions, although rare, can also limit wider acceptance. To navigate these challenges, firms should focus on robust research and development initiatives, aiming at innovations in vaccine delivery systems, and improving vaccine safety profiles. The nature of the market is highly competitive, with continual innovation from key players aiming to expand their share through diversified product portfolios. Increasing technological integration, such as AI-driven data analytics for personalized vaccine schedules, represents fertile ground for future exploration. Companies should also consider collaborations with governmental and health agencies to enhance public trust and regulatory compliance, ensuring an upward trajectory in the acceptance and application of canine vaccines.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dog Vaccines Market

The Dog Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing pet ownership and rising awareness about animal health and vaccinations
  • Government initiatives and regulations supporting mandatory pet vaccinations and animal disease control
  • Rising incidences of zoonotic diseases and the role of vaccines in prevention
  • Advancements in veterinary medicine and increasing investment in pet healthcare infrastructure
• Market Restraints
  • Lack of awareness and education among pet owners about the importance of dog vaccination
  • Stringent regulatory requirements and lengthy approval process for dog vaccines causing delays
• Market Opportunities
  • Advancements in biotechnology leading to development of more effective vaccines for common canine diseases
  • Rising investment in research and development for next-generation dog vaccines with fewer side effects
  • Collaboration between veterinary pharmaceutical companies and research institutions to create innovative vaccine solutions
• Market Challenges
  • Navigating fluctuating regulatory landscapes for approval and distribution of dog vaccines
  • Balancing the rising costs of research, development, and production in the dog vaccine industry

Porter's Five Forces: A Strategic Tool for Navigating the Dog Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dog Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dog Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dog Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dog Vaccines Market

A detailed market share analysis in the Dog Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dog Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dog Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dog Vaccines Market

A strategic analysis of the Dog Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dog Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Inc., Bayer Animal Health GmbH, Biogenesis Bago, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Heska Corporation, Hipra, IDEXX Laboratories, Inc., Intas Pharmaceuticals Ltd., Kyoritsu Seiyaku Corporation, Merck & Co., Inc., Merial Ltd., Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Dog Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Vaccine Type, market is studied across Core Vaccines and Non-Core Vaccines. The Core Vaccines is further studied across Canine Adenovirus, Canine Distemper Virus, Canine Parvovirus, and Rabies. The Non-Core Vaccines is further studied across Bordetella Bronchiseptica, Borrelia Burgdorferi, and Leptospira Canicola.
• Based on Technology, market is studied across DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, and Recombinant Vaccines.
• Based on End User, market is studied across Animal Hospitals, Pet Clinics, Research Institutes, and Veterinary Clinics.
• Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, Vaccination Camps, and Veterinary Clinics & Hospitals.
• Based on Application, market is studied across Disease Prevention and Therapeutic.
• Based on Age Group, market is studied across Adult Dogs, Puppies, and Senior Dogs.
• Based on Dog Size, market is studied across Giant Breed, Large Breed, Medium Breed, and Small Breed.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing pet ownership and rising awareness about animal health and vaccinations
    • 5.1.1.2. Government initiatives and regulations supporting mandatory pet vaccinations and animal disease control
    • 5.1.1.3. Rising incidences of zoonotic diseases and the role of vaccines in prevention
    • 5.1.1.4. Advancements in veterinary medicine and increasing investment in pet healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of awareness and education among pet owners about the importance of dog vaccination
    • 5.1.2.2. Stringent regulatory requirements and lengthy approval process for dog vaccines causing delays
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in biotechnology leading to development of more effective vaccines for common canine diseases
    • 5.1.3.2. Rising investment in research and development for next-generation dog vaccines with fewer side effects
    • 5.1.3.3. Collaboration between veterinary pharmaceutical companies and research institutions to create innovative vaccine solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Navigating fluctuating regulatory landscapes for approval and distribution of dog vaccines
    • 5.1.4.2. Balancing the rising costs of research, development, and production in the dog vaccine industry
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Dog Vaccines Market, by Vaccine Type

• 6.1. Introduction
• 6.2. Core Vaccines
  • 6.2.1. Canine Adenovirus
  • 6.2.2. Canine Distemper Virus
  • 6.2.3. Canine Parvovirus
  • 6.2.4. Rabies
• 6.3. Non-Core Vaccines
  • 6.3.1. Bordetella Bronchiseptica
  • 6.3.2. Borrelia Burgdorferi
  • 6.3.3. Leptospira Canicola

7. Dog Vaccines Market, by Technology

• 7.1. Introduction
• 7.2. DNA Vaccines
• 7.3. Inactivated Vaccines
• 7.4. Live Attenuated Vaccines
• 7.5. Recombinant Vaccines

8. Dog Vaccines Market, by End User

• 8.1. Introduction
• 8.2. Animal Hospitals
• 8.3. Pet Clinics
• 8.4. Research Institutes
• 8.5. Veterinary Clinics

9. Dog Vaccines Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Online Pharmacies
• 9.3. Retail Pharmacies
• 9.4. Vaccination Camps
• 9.5. Veterinary Clinics & Hospitals

10. Dog Vaccines Market, by Application

• 10.1. Introduction
• 10.2. Disease Prevention
• 10.3. Therapeutic

11. Dog Vaccines Market, by Age Group

• 11.1. Introduction
• 11.2. Adult Dogs
• 11.3. Puppies
• 11.4. Senior Dogs

12. Dog Vaccines Market, by Dog Size

• 12.1. Introduction
• 12.2. Giant Breed
• 12.3. Large Breed
• 12.4. Medium Breed
• 12.5. Small Breed

13. Americas Dog Vaccines Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Dog Vaccines Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Dog Vaccines Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aratana Therapeutics, Inc.
• 2. Bayer Animal Health GmbH
• 3. Biogenesis Bago
• 4. Boehringer Ingelheim Animal Health
• 5. Ceva Sante Animale
• 6. Chanelle Pharma Group
• 7. Dechra Pharmaceuticals PLC
• 8. Elanco Animal Health Incorporated
• 9. Heska Corporation
• 10. Hipra
• 11. IDEXX Laboratories, Inc.
• 12. Intas Pharmaceuticals Ltd.
• 13. Kyoritsu Seiyaku Corporation
• 14. Merck & Co., Inc.
• 15. Merial Ltd.
• 16. Neogen Corporation
• 17. Phibro Animal Health Corporation
• 18. Vetoquinol S.A.
• 19. Virbac S.A.
• 20. Zoetis Inc.